When was BioChain founded?

BioChain was founded in 1994 and raised its 1st funding round 14 years after it was founded.

Where is BioChain located?

BioChain is headquartered in Hayward, United States. It is registered at 39600 Eureka Drive Newark, CA 94560.

How many employees does BioChain have?

As of Apr 30, 2026, the latest employee count at BioChain is 39.

Is BioChain a funded company?

BioChain is a funded company, having raised a total of $7.34M across 2 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on May 05, 2008.

When was the latest funding round of BioChain?

BioChain's latest funding was a $***** PE round on Nov 11, 2016, with participation from 1 investor.

Where does BioChain rank among its competitors?

BioChain ranks 50th amongst 883 active competitors, of which 63 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was BioLamina, which secured $23.6M in Apr, 2026.

Who are the top competitors of BioChain?

BioChain's top competitors include Abcam, Enzo and Sino Biological. Among them, BioLamina secured the most recent funding round in April, 2026.

BioChain - 2026 Company Profile, Team, Funding & Competitors

BioChain is a late stage company based in Hayward (United States), founded in 1994. It operates as a Provider of products and services for clinical diagnosis, genomics, and proteomics. BioChain has raised $7.34M in funding from Ascendent Capital Partners. The company has 883 active competitors, including 63 funded and 119 that have exited. Its top competitors include companies like Abcam, Enzo and Sino Biological.

Company Details

Provider of products and services for clinical diagnosis, genomics, and proteomics. The products (markers, kits, reagents) for DNA/RNA and proteins related research. It provides kits for sequencing, enzyme assays, PCR, immunodiagnostics. Also offers an extensive collection of tissue blocks, slides, frozen arrays, and FFPE arrays for human normal, diseased, and tumor tissue types. It provides custom services such as clinical samples collection, extraction and purification, tissue section and array, and others.

Website: www.biochain.com/
Social
Registered Address: 39600 Eureka Drive Newark, CA 94560

Key Metrics

Founded Year

1994

Location

Hayward, United States

Stage

Late Stage

Total Funding

$7.34M in 2 rounds

Latest Funding Round

PE, Nov 11, 2016, $*****

Investors

Ascendent Capital Partners & 2 more

Ranked

50^th among 883 active competitors

Employee Count

39 as on Apr 30, 2026

Investment & Acquisitions

Epigenomics & 1 more

Similar Companies

Abcam & 1053 more

View BioChain's full profile

BioChain is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Biochain Institute, Inc. CIN: 943203937 , United States, Active	Dec 31, 1999	-	24 (As on Dec 31, 2024)	-

BioChain has raised a total funding of $7.34M over 2 rounds. Its first funding round was on May 05, 2008. Its latest funding round was a PE round on Nov 11, 2016 for $*****. 1 investor participated in its latest round. BioChain has 3 institutional investors.

Here is the list of recent funding rounds of BioChain:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 11, 2016	1945289	PE	3250685	3428121	5137420	1858928
May 05, 2008	5598748	Grant (prize money)	6845164	4734515	5586070	HHS

Access funding benchmarks and valuations. Sign up today!

View details of BioChain's funding rounds and investors

BioChain's employee count trend

BioChain has 39 employees as of Apr 26. Here is BioChain's employee count trend over the years:

Uncover BioChain's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of BioChain include Abcam, Enzo and Sino Biological. Here is the list of Top 10 competitors of BioChain, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Abcam 1998, Cambridge (United Kingdom), Acquired	Developer of biological reagents for life science research	$78.8M	Juno Investment Partners, Martlet Capital ... & 2 others	75/100
2nd	Enzo 1976, Farmingdale (United States), Acquired	Life science products and services for research, drug discovery, and manufacturing	$7M	-	67/100
3rd	Sino Biological 2007, Beijing (China), Series A	Provider of reagents,and kits for clinical research	$29.4M	Qiming Venture Partners, CTS Capital & 1 others	67/100
4th	Meridian Bioscience 1976, Ohio (United States), Acquired	Molecular diagnostic device and kits	-	JobsOhio, NIH	65/100
5th	Devyser 2004, Stockholm (Sweden), Public	Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders	$15.5M	Swedbank Robur, Fjarde AP-fonden & 1 others	61/100
6th	Miltenyi Biotec 1989, Bergisch Gladbach (Germany), Funding Raised	Develops tools and products for research and clinical application	-	Europa, HHS	59/100
7th	Stem Cell Technologies 1993, Vancouver (Canada), Series A	Developer of cell culture media and ancillary reagents for life science research	$11.9M	National Research Council Canada, BDC & 1 others	58/100
8th	BioLamina 2008, Sundbyberg (Sweden), Series B	Cell culture reagents for stem cell research	$18.2M	Lauxera Capital Partners, Bure Equity & 5 others	56/100
9th	BioIVT 1981, Westbury (United States), Acquired	Provider of in vitro diagnostic products and assay services	-	Thompson Street Capital Partners, National Science Foundation ... & 4 others	56/100
10th	GenScript 2002, Piscataway (United States), Public	Provider of reagents and instruments for life sciences research	$15M	Kleiner Perkins, Vermögensclub & 1 others	55/100
50th	BioChain 1994, Hayward (United States), Late Stage	Provider of products and services for clinical diagnosis, genomics, and proteomics	$7.34M	Ascendent Capital Partners, Summitview Capital ... & 1 others	43/100